Sign In

Hil Moss

Yale MBA/MPH building something new in survivorship - Cancer Advocate - Digital Health - Patient-Centered Innovation

Professional Background

Hil Moss is a dynamic MBA/MPH candidate at Yale University, specializing in innovation and entrepreneurship within the realms of cancer care and women’s health. A spirited advocate and a young breast cancer survivor herself, Hil has channeled her personal experiences into a mission to transform the cancer care landscape. As an active mentor and contributor to the cancer community, her written works have been featured in prestigious publications such as New York Magazine, Cell, and STAT, where she raises her voice to enhance awareness on the significance of early detection and to improve patient experiences.

In addition to her advocacy work, Hil serves as an independent consultant, guiding corporations on patient-centered innovation and corporate strategy, leveraging her extensive expertise to create impactful healthcare solutions. Her diverse skill set encompasses strategic visioning, marketing, content creation, research and insights, as well as new business development—all critical in driving meaningful transformation in health care.

Outside of her professional commitments, Hil enjoys public speaking engagements, showcasing her expertise and passion for cancer advocacy. With a fondness for musical comedy and nature, she balances her professional zeal with creative outlets, embodying a well-rounded approach to life and work.

Education and Achievements

Hil's academic journey is marked by her commitment to intertwining her passion for health and business. She began her studies at Princeton University, where she earned an AB in Art and Archaeology. This foundation in the liberal arts has undoubtedly enriched her perspective in public health and business.

Following her undergraduate education, Hil pursued advanced degrees at Yale University. She is currently enrolled in the Master of Business Administration (MBA) program at the Yale School of Management and the Master of Public Health (MPH) program at the Yale School of Public Health. This dual-degree pursuit underscores her dedication to marrying business acumen with public health knowledge, preparing her for leadership roles in healthcare innovation.

Hil's involvement in various organizations complements her academic achievements. As Co-Chair of the 2022 Yale Healthcare Conference, she took on a pivotal role in orchestrating discussions around healthcare advancements. Moreover, her previous appointment as a Student Fellow at the Solomon Center for Health Law and Policy at Yale Law School has further honed her understanding of the intersection between law and health policy.

Her impressive career began at Hologic, Inc., where she not only served as an MBA Intern in the Breast Surgery Division but also contributed as a Senior Consultant. Her work involved developing strategies that directly influence patient care and innovation in women's health.

Throughout her career, Hil has held several strategic positions that have allowed her to blend her expertise in healthcare with a passion for advocacy and innovation. Her tenure as a Senior Strategist at LaPlaca Cohen provided her with valuable experience in implementing marketing strategies that resonate with target audiences in the health sector. Additionally, her time as a Cultural Centre Coordinator at BAYIMBA exemplifies her versatility and dedication to strategic planning across diverse domains.

Achievements

Hil's commitment to cancer advocacy and healthcare innovation has led her to achieve several notable milestones:

  • Highly Regarded Writer: Published articles in well-respected outlets, including New York Magazine, Cell, and STAT, where she addresses crucial topics in cancer care and patient experience.
  • Thought Leader and Advocate: Actively contributes to raising awareness around cancer issues as a young breast cancer survivor, providing hope and guidance to others facing similar journeys.
  • Mousepreneurship in Healthcare: As an independent consultant, Hil has worked with various companies, offering insights on patient-centered innovation, significantly advancing corporate strategies in health.
  • Leadership Roles: As Co-Chair of the Yale Healthcare Conference, Hil successfully led discussions on vital topics in healthcare, showcasing her ability to rally experts and amplify critical conversations in the industry.
  • Strategic Development Contributions: Supported advanced patient care initiatives through her roles at Hologic and Thrive, An Exact Sciences Company, where she focused on launching, accessing, and adopting innovative healthcare solutions.
  • Recognition for Mentorship: Her role as a mentor in the cancer community highlights her dedication to uplifting others and contributing to stronger networks within healthcare advocacy.
  • Academic Excellence: While pursuing dual master's degrees at Yale, her commitment to academic rigor and practical applications of her studies showcase her dedication to becoming a leader in heal

Highlights

Aug 20 · linkedin

Thanks to Mary Caffrey for this feature on OncoveryCare—and our partnership to "power" Tennessee Oncology's survivorship care—in the most recent issue of AJMC - The American Journal of Managed Care.

It was a great chance to share a bit about what we are building and why at Oncovery, as well as to hear from the incredible Dr. Natalie Dickson, President & CEO of Tennessee Oncology. To quote her:

“By collaborating with OncoveryCare and leveraging our practice’s resources and clinical knowledge, we aim to create tailored protocols and systems to support the unique needs of the growing population of patients,” she told EBO. “Processes which should be easily adapted and implemented by practices of varying sizes and capabilities. Our initiative aligns with ASCO-COA oncology medical home certification standards, enhancing comprehensive oncology care delivery. Ultimately, this investment underscores our commitment to improving survivorship care and upholding quality and value standards, in line with the principles advocated through my work with ASCO and COA.”

You can read more here:

May 23 · linkedin

Today, I'm excited to share the next chapter in our mission to radically redefine cancer survivorship care.

When I was in my final year of grad school and decided to make the jump to start our cancer survivorship company—which, today, reintroduces itself as OncoveryCare—I would fantasize about what it would be like to work arm-in-arm with a team on this mission. That's why the highlight of the past two years, by far, has been meeting my amazing Co-Founder, Dr. Justin Grischkan; our Founding Team members Natasha Steele, MD, MPH and Alicia Tan; and every single one of our incredible team members, advisors, and early investors.

This morning, we officially introduce some incredible additions to Team Oncovery, as we announce both our anchor partnership with Tennessee Oncology (led by the incredible Dr. Natalie Dickson), as well as our $4.5 million Seed financing led by .406 Ventures alongside Tennessee Oncology's McKay Institute for Innovation. Existing investors Oncology Ventures & Techstars continue supporting our vision as well.

So much to share on this in the days and weeks ahead, but you can read more here, and we figured we'd re-introduce ourselves (with new faces!) in the video below. https://lnkd.in/e8M6UvCa

As always, grateful to be on this journey together.

Related Questions

How has Hil Moss's experience as a young breast cancer survivor shaped her approach to healthcare innovation?
In what ways does Hil Moss integrate her background in business and public health in her consulting work?
What impact has Hil Moss had on the cancer community through her writing and advocacy efforts?
How does Hil Moss envision the future of patient-centered innovation in cancer care and women's health?
What leadership qualities does Hil Moss exemplify through her role as Co-Chair of the Yale Healthcare Conference?
Hil Moss
Add to my network

Location

New Haven, Connecticut, United States